Related Experiment Videos
Exploring Translational Medical Research Progress in G20 Countries: 5-Year Study
Hana A Alhumud1, Fars K Alanazi2, Edward B DeVol3
1Head of Research and Innovation Impact Measurement Unit, Saudi National Institute of Health, Riyadh, Kingdom of Saudi Arabia.
Saudi Medical Journal
|August 14, 2026
Summary
Translational research, crucial for public health, shows no single success formula across Group of 20 (G20) countries. Collaboration and diverse approaches are key to improving biomedical research outcomes.
Area of Science:
- Biomedical Research
- Translational Science
- Public Health
Background:
- Biomedical research is vital for health advancements but often disjointed.
- Translational research aims to streamline the progression of research findings.
- Addressing delays and missed opportunities in the research pipeline is critical.
Purpose of the Study:
- To identify research activities linked to translational research.
- To analyze patterns in translational research focus and progress.
- To examine publications from Group of 20 (G20) countries over five years.
Main Methods:
- Analysis of approximately 40,000 research publications.
- Utilized data from the Web of Science database.
- Focused on publications from G20 nations within the last five years.
Main Results:
- No universal model for successful translational research exists across G20 nations.
- Factors influencing translational research success vary significantly by country.
- Each nation's historical research successes and failures impact current outcomes.
Conclusions:
- Global research collaboration enhances predictability and outcomes in translational research.
- Diverse perspectives increase the potential for success in research activities.
- A connected, coordinated approach to biomedical research is essential for greater health impact.
Related Concept Videos
02:24Ribosome Profiling
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
02:07Improving Translational Accuracy
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
02:07Improving Translational Accuracy
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...